Dry Eyes – Researchers
find Protein plays a role in Dry and Infected Eyes
May 17th, 2006
|
 |
|
Mina Massaro-Giordano,
M.D., (left) with Marcella Macaluso, Ph.D
Photo by Joseph Labolito/Temple University |
|
Researchers from the University of
Pennsylvania and Temple University discovered the Plasminogen Activator
Inhibitor Type 2 (PAI-2) protein in a variety of cell types. The PAI-2
was found in skin and in tissue covering the eye. The discovery of the
PAI-2 may lead to new treatments for outside eye surfaces including dry
eyes and eye infections.
The lead researchers are Mina
Massaro-Giordano, M.D., of the University of Pennsylvania’s Scheie Eye
Institute, and Marcella Macaluso, Ph.D., of the Sbarro Institute for
Cancer Research at Temple University. They first published the results
of this study in the Nature’s journal called Cell Death and
Differentiation. They have also shared the findings at the annual
meeting of the Association of Research in Vision and Ophthalmology (ARVO)
in Florida.
PAI-2 can come in an extracellular
or a secreted form. This protein helps to regulate cell proliferation
and prevent programmed cell death. The PAI-2 also helps to silence the
microbial proteinases and help defend against stromal degradation.
It is believed that the health
benefits of having high levels of PAI-2 protein will improve the outcome
for some cancers by slowing down metastasis. PAI-2 also is believed to
participate when there is inflammation on the surface of the eye.
|